Rodrigo Fonseca

ORCID

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 16

Top Venues

Nature communications

Blood cancer journal

Hospital practice (1995)

Blood cancer discovery

This page only lists publications with an associated author ORCID identifier.

Publications

Natthakan Thongon, Feiyang Ma, Natalia Baran, Pamela Lockyer, Jintan Liu, Christopher Jackson, Ashley Rose, Ken Furudate, Bethany Wildeman, Matteo Marchesini, Valentina Marchica, Paola Storti, Giannalisa Todaro, Irene Gañán-Gómez, Vera Adema, Juan Jose Rodriguez-Sevilla, Yun Qing, Min Jin Ha, Rodrigo Fonseca, Caleb Stein, Caleb A Class, Lin Tan, Sergio Attanasio, Guillermo Garcia Manero, Nicola Giuliani, David Berrios Nolasco, Andrea Santoni, Claudio Cerchione, Carlos E Bueso-Ramos, Marina Konopleva, Philip L Lorenzi, Koichi Takahashi, Elisabet Manasanch, Gabriella Sammarelli, Rashmi Kanagal-Shamana, Andrea Viale, Marta Chesi, Simona Colla
Targeting DNA2 overcomes metabolic reprogramming in multiple myeloma. Nature communications 15 (1) (2024)
Natthakan Thongon, Feiyang Ma, Natalia Baran, Pamela Lockyer, Jintan Liu, Christopher Jackson, Ashley Rose, Ken Furudate, Bethany Wildeman, Matteo Marchesini, Valentina Marchica, Paola Storti, Giannalisa Todaro, Irene Gañán-Gómez, Vera Adema, Juan Jose Rodriguez-Sevilla, Yun Qing, Min Jin Ha, Rodrigo Fonseca, Caleb Stein, Caleb A Class, Lin Tan, Sergio Attanasio, Guillermo Garcia Manero, Nicola Giuliani, David Berrios Nolasco, Andrea Santoni, Claudio Cerchione, Carlos E Bueso-Ramos, Marina Konopleva, Philip L Lorenzi, Koichi Takahashi, Elisabet Manasanch, Gabriella Sammarelli, Rashmi Kanagal-Shamana, Andrea Viale, Marta Chesi, Simona Colla
Targeting DNA2 overcomes metabolic reprogramming in multiple myeloma. Nature communications 15 (1) (2024)
Natthakan Thongon, Feiyang Ma, Natalia Baran, Pamela Lockyer, Jintan Liu, Christopher Jackson, Ashley Rose, Ken Furudate, Bethany Wildeman, Matteo Marchesini, Valentina Marchica, Paola Storti, Giannalisa Todaro, Irene Gañán-Gómez, Vera Adema, Juan Jose Rodriguez-Sevilla, Yun Qing, Min Jin Ha, Rodrigo Fonseca, Caleb Stein, Caleb A Class, Lin Tan, Sergio Attanasio, Guillermo Garcia Manero, Nicola Giuliani, David Berrios Nolasco, Andrea Santoni, Claudio Cerchione, Carlos E Bueso-Ramos, Marina Konopleva, Philip L Lorenzi, Koichi Takahashi, Elisabet Manasanch, Gabriella Sammarelli, Rashmi Kanagal-Shamana, Andrea Viale, Marta Chesi, Simona Colla
Targeting DNA2 overcomes metabolic reprogramming in multiple myeloma. Nature communications 15 (1) (2024)
Natthakan Thongon, Feiyang Ma, Natalia Baran, Pamela Lockyer, Jintan Liu, Christopher Jackson, Ashley Rose, Ken Furudate, Bethany Wildeman, Matteo Marchesini, Valentina Marchica, Paola Storti, Giannalisa Todaro, Irene Gañán-Gómez, Vera Adema, Juan Jose Rodriguez-Sevilla, Yun Qing, Min Jin Ha, Rodrigo Fonseca, Caleb Stein, Caleb A Class, Lin Tan, Sergio Attanasio, Guillermo Garcia Manero, Nicola Giuliani, David Berrios Nolasco, Andrea Santoni, Claudio Cerchione, Carlos E Bueso-Ramos, Marina Konopleva, Philip L Lorenzi, Koichi Takahashi, Elisabet Manasanch, Gabriella Sammarelli, Rashmi Kanagal-Shamana, Andrea Viale, Marta Chesi, Simona Colla
Targeting DNA2 overcomes metabolic reprogramming in multiple myeloma. Nature communications 15 (1) (2024)
Natthakan Thongon, Feiyang Ma, Natalia Baran, Pamela Lockyer, Jintan Liu, Christopher Jackson, Ashley Rose, Ken Furudate, Bethany Wildeman, Matteo Marchesini, Valentina Marchica, Paola Storti, Giannalisa Todaro, Irene Gañán-Gómez, Vera Adema, Juan Jose Rodriguez-Sevilla, Yun Qing, Min Jin Ha, Rodrigo Fonseca, Caleb Stein, Caleb A Class, Lin Tan, Sergio Attanasio, Guillermo Garcia Manero, Nicola Giuliani, David Berrios Nolasco, Andrea Santoni, Claudio Cerchione, Carlos E Bueso-Ramos, Marina Konopleva, Philip L Lorenzi, Koichi Takahashi, Elisabet Manasanch, Gabriella Sammarelli, Rashmi Kanagal-Shamana, Andrea Viale, Marta Chesi, Simona Colla
Targeting DNA2 overcomes metabolic reprogramming in multiple myeloma. Nature communications 15 (1) (2024)
Natthakan Thongon, Feiyang Ma, Natalia Baran, Pamela Lockyer, Jintan Liu, Christopher Jackson, Ashley Rose, Ken Furudate, Bethany Wildeman, Matteo Marchesini, Valentina Marchica, Paola Storti, Giannalisa Todaro, Irene Gañán-Gómez, Vera Adema, Juan Jose Rodriguez-Sevilla, Yun Qing, Min Jin Ha, Rodrigo Fonseca, Caleb Stein, Caleb A Class, Lin Tan, Sergio Attanasio, Guillermo Garcia Manero, Nicola Giuliani, David Berrios Nolasco, Andrea Santoni, Claudio Cerchione, Carlos E Bueso-Ramos, Marina Konopleva, Philip L Lorenzi, Koichi Takahashi, Elisabet Manasanch, Gabriella Sammarelli, Rashmi Kanagal-Shamana, Andrea Viale, Marta Chesi, Simona Colla
Targeting DNA2 overcomes metabolic reprogramming in multiple myeloma. Nature communications 15 (1) (2024)
Mercedes Martinez Gil, Rodrigo Fonseca, Leila K Tehrani, Janna C Castro, Shon E Meek, Bithika M Thompson, Curtiss B Cook
Assessing outcomes of intravenous insulin therapy in non-intensive care patients. Hospital practice (1995) (2024)
Natthakan Thongon, Feiyang Ma, Natalia Baran, Pamela Lockyer, Jintan Liu, Christopher Jackson, Ashley Rose, Ken Furudate, Bethany Wildeman, Matteo Marchesini, Valentina Marchica, Paola Storti, Giannalisa Todaro, Irene Gañán-Gómez, Vera Adema, Juan Jose Rodriguez-Sevilla, Yun Qing, Min Jin Ha, Rodrigo Fonseca, Caleb Stein, Caleb A Class, Lin Tan, Sergio Attanasio, Guillermo Garcia Manero, Nicola Giuliani, David Berrios Nolasco, Andrea Santoni, Claudio Cerchione, Carlos E Bueso-Ramos, Marina Konopleva, Philip L Lorenzi, Koichi Takahashi, Elisabet Manasanch, Gabriella Sammarelli, Rashmi Kanagal-Shamana, Andrea Viale, Marta Chesi, Simona Colla
Targeting DNA2 overcomes metabolic reprogramming in multiple myeloma. Nature communications 15 (1) (2024)
Natthakan Thongon, Feiyang Ma, Natalia Baran, Pamela Lockyer, Jintan Liu, Christopher Jackson, Ashley Rose, Ken Furudate, Bethany Wildeman, Matteo Marchesini, Valentina Marchica, Paola Storti, Giannalisa Todaro, Irene Gañán-Gómez, Vera Adema, Juan Jose Rodriguez-Sevilla, Yun Qing, Min Jin Ha, Rodrigo Fonseca, Caleb Stein, Caleb A Class, Lin Tan, Sergio Attanasio, Guillermo Garcia Manero, Nicola Giuliani, David Berrios Nolasco, Andrea Santoni, Claudio Cerchione, Carlos E Bueso-Ramos, Marina Konopleva, Philip L Lorenzi, Koichi Takahashi, Elisabet Manasanch, Gabriella Sammarelli, Rashmi Kanagal-Shamana, Andrea Viale, Marta Chesi, Simona Colla
Targeting DNA2 overcomes metabolic reprogramming in multiple myeloma. Nature communications 15 (1) (2024)
Natthakan Thongon, Feiyang Ma, Natalia Baran, Pamela Lockyer, Jintan Liu, Christopher Jackson, Ashley Rose, Ken Furudate, Bethany Wildeman, Matteo Marchesini, Valentina Marchica, Paola Storti, Giannalisa Todaro, Irene Gañán-Gómez, Vera Adema, Juan Jose Rodriguez-Sevilla, Yun Qing, Min Jin Ha, Rodrigo Fonseca, Caleb Stein, Caleb A Class, Lin Tan, Sergio Attanasio, Guillermo Garcia Manero, Nicola Giuliani, David Berrios Nolasco, Andrea Santoni, Claudio Cerchione, Carlos E Bueso-Ramos, Marina Konopleva, Philip L Lorenzi, Koichi Takahashi, Elisabet Manasanch, Gabriella Sammarelli, Rashmi Kanagal-Shamana, Andrea Viale, Marta Chesi, Simona Colla
Targeting DNA2 overcomes metabolic reprogramming in multiple myeloma. Nature communications 15 (1) (2024)
Rodrigo Fonseca, Mariano Arribas, Julia E Wiedmeier-Nutor, Yael N Kusne, Miguel González Vélez, Heidi E Kosiorek, Richard Duke J Butterfield, Ilan R Kirsch, Joseph R Mikhael, A Keith Stewart, Craig B Reeder, Jeremy Larsen, Peter Leif Bergsagel, Rafael Fonseca
Integrated analysis of next generation sequencing minimal residual disease (MRD) and PET scan in transplant eligible myeloma patients. Blood cancer journal 13 (1) (2023)
Rodrigo Fonseca, Mariano Arribas, Julia E Wiedmeier-Nutor, Yael N Kusne, Miguel González Vélez, Heidi E Kosiorek, Richard Duke J Butterfield, Ilan R Kirsch, Joseph R Mikhael, A Keith Stewart, Craig B Reeder, Jeremy Larsen, Peter Leif Bergsagel, Rafael Fonseca
Integrated analysis of next generation sequencing minimal residual disease (MRD) and PET scan in transplant eligible myeloma patients. Blood cancer journal 13 (1) (2023)
Seth J Welsh, Benjamin G Barwick, Erin W Meermeier, Daniel L Riggs, Chang-Xin Shi, Yuan Xiao Zhu, Meaghen E Sharik, Megan T Du, Leslie D Abrego Rocha, Victoria M Garbitt, Caleb K Stein, Joachim L Petit, Nathalie Meurice, Yuliza Tafoya Alvarado, Rodrigo Fonseca, Kennedi T Todd, Sochilt Brown, Zachary J Hammond, Nicklus H Cuc, Courtney Wittenberg, Camille Herzog, Anna V Roschke, Yulia N Demchenko, Wei-Dong D Chen, Peng Li, Wei Liao, Warren J Leonard, Sagar Lonial, Nizar J Bahlis, Paola Neri, Lawrence H Boise, Marta Chesi, Peter Leif Bergsagel
Transcriptional heterogeneity overcomes super-enhancer disrupting drug combinations in multiple myeloma. Blood cancer discovery (2023)
Rodrigo Fonseca, Mariano Arribas, Julia E Wiedmeier-Nutor, Yael N Kusne, Miguel González Vélez, Heidi E Kosiorek, Richard Duke J Butterfield, Ilan R Kirsch, Joseph R Mikhael, A Keith Stewart, Craig B Reeder, Jeremy Larsen, Peter Leif Bergsagel, Rafael Fonseca
Integrated analysis of next generation sequencing minimal residual disease (MRD) and PET scan in transplant eligible myeloma patients. Blood cancer journal 13 (1) (2023)
Rodrigo Fonseca, Mariano Arribas, Julia E Wiedmeier-Nutor, Yael N Kusne, Miguel González Vélez, Heidi E Kosiorek, Richard Duke J Butterfield, Ilan R Kirsch, Joseph R Mikhael, A Keith Stewart, Craig B Reeder, Jeremy Larsen, Peter Leif Bergsagel, Rafael Fonseca
Integrated analysis of next generation sequencing minimal residual disease (MRD) and PET scan in transplant eligible myeloma patients. Blood cancer journal 13 (1) (2023)
Rodrigo Fonseca, Mariano Arribas, Julia E Wiedmeier-Nutor, Yael N Kusne, Miguel González Vélez, Heidi E Kosiorek, Richard Duke J Butterfield, Ilan R Kirsch, Joseph R Mikhael, A Keith Stewart, Craig B Reeder, Jeremy Larsen, Peter Leif Bergsagel, Rafael Fonseca
Correction: Integrated analysis of next generation sequencing minimal residual disease (MRD) and PET scan in transplant eligible myeloma patients. Blood cancer journal 13 (1) (2023)

Rodrigo Fonseca.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Rodrigo Fonseca